Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CELC Celcuity	$50.06 +7.3%	$19.30	$7.57 ▼ $50.33	$1.95B	0.68	566,186 shs	959,105 shs
LFST LifeStance Health Group	$4.66 +2.0%	$4.75	$3.74 ▼ $8.61	$1.81B	1.13	1.94 million shs	3.05 million shs
PACS PACS Group	$11.22 -1.2%	$11.86	$8.28 ▼ $43.92	$1.71B	0.88	548,293 shs	368,007 shs
SBC SBC Medical Group	$4.54 +2.3%	$4.68	$2.62 ▼ $19.50	$470.39M	1.27	67,923 shs	64,940 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CELC Celcuity	+1.70%	+8.18%	+242.33%	+331.24%	+189.27%
LFST LifeStance Health Group	+4.58%	+17.18%	+1.33%	-22.15%	-18.39%
PACS PACS Group	+1.83%	+3.41%	-10.17%	+4.07%	-65.33%
SBC SBC Medical Group	+0.91%	+2.78%	-12.08%	+26.86%	+443,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CELC Celcuity	0.6249 of 5 stars	1.5	1.0	0.0	0.0	1.1	3.3	0.0
LFST LifeStance Health Group	3.2041 of 5 stars	3.4	4.0	0.0	0.0	2.6	2.5	0.6
PACS PACS Group	3.113 of 5 stars	3.4	3.0	0.0	0.0	1.2	0.0	1.9
SBC SBC Medical Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CELC Celcuity	3.00	Buy	$39.20	-21.69% Downside
LFST LifeStance Health Group	2.86	Moderate Buy	$8.50	82.40% Upside
PACS PACS Group	2.86	Moderate Buy	$34.29	205.60% Upside
SBC SBC Medical Group	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest SBC, PACS, CELC, and LFST Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/8/2025	LFST LifeStance Health Group	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$8.50 ➝ $9.00
7/28/2025	CELC Celcuity	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$28.00 ➝ $60.00
7/28/2025	CELC Celcuity	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$27.00 ➝ $50.00
7/28/2025	CELC Celcuity	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$29.00
7/25/2025	LFST LifeStance Health Group	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$8.00
7/1/2025	CELC Celcuity	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$30.00
6/30/2025	CELC Celcuity	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$29.00
5/27/2025	LFST LifeStance Health Group	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$8.50
5/19/2025	CELC Celcuity	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$27.00 ➝ $27.00
5/15/2025	CELC Celcuity	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$29.00 ➝ $29.00

(Data available from 8/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CELC Celcuity	N/A	N/A	N/A	N/A	$3.11 per share	N/A
LFST LifeStance Health Group	$1.25B	1.45	$0.04 per share	110.21	$3.78 per share	1.23
PACS PACS Group	$3.11B	0.55	N/A	N/A	N/A	∞
SBC SBC Medical Group	$205.42M	2.29	$0.63 per share	7.26	$1.90 per share	2.39

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CELC Celcuity	-$111.78M	-$3.03	N/A	N/A	N/A	N/A	-96.21%	-49.44%	8/14/2025 (Estimated)
LFST LifeStance Health Group	-$57.44M	-$0.05	N/A	N/A	N/A	-1.23%	-1.12%	-0.77%	N/A
PACS PACS Group	$112.87M	N/A	0.00	6.30	N/A	N/A	N/A	N/A	N/A
SBC SBC Medical Group	$46.61M	N/A	0.00	0.81	N/A	N/A	26.72%	19.60%	8/13/2025 (Estimated)

Latest SBC, PACS, CELC, and LFST Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	CELC Celcuity	-$0.94	N/A	N/A	N/A	N/A	N/A
8/13/2025	Q2 2025	SBC SBC Medical Group	$0.14	N/A	N/A	N/A	$44.71 million	N/A
8/7/2025	Q2 2025	LFST LifeStance Health Group	-$0.03	-$0.01	+$0.02	-$0.01	$345.05 million	$345.31 million
5/15/2025	Q1 2025	SBC SBC Medical Group	$0.11	$0.21	+$0.10	$0.21	$51.52 million	$47.33 million
5/14/2025	Q1 2025	CELC Celcuity	-$0.95	-$0.86	+$0.09	-$0.86	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CELC Celcuity	N/A	N/A	N/A	N/A	N/A
LFST LifeStance Health Group	N/A	N/A	N/A	N/A	N/A
PACS PACS Group	N/A	N/A	N/A	N/A	N/A
SBC SBC Medical Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CELC Celcuity	1.14	6.61	6.61
LFST LifeStance Health Group	0.19	1.47	1.47
PACS PACS Group	N/A	N/A	N/A
SBC SBC Medical Group	0.03	4.44	4.40

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CELC Celcuity	63.33%
LFST LifeStance Health Group	85.50%
PACS PACS Group	N/A
SBC SBC Medical Group	60.82%

Insider Ownership

Company	Insider Ownership
CELC Celcuity	15.78%
LFST LifeStance Health Group	6.60%
PACS PACS Group	N/A
SBC SBC Medical Group	89.47%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CELC Celcuity	40	38.91 million	32.77 million	Optionable
LFST LifeStance Health Group	10,218	388.94 million	363.27 million	Optionable
PACS PACS Group	32,433	152.40 million	N/A	Optionable
SBC SBC Medical Group	N/A	103.61 million	10.91 million	N/A

SBC, PACS, CELC, and LFST Headlines

Recent News About These Companies

SBC Medical Group (SBC) Projected to Post Quarterly Earnings on Wednesday

August 7, 2025 | marketbeat.com

SBC Medical Group (NASDAQ:SBC) Stock Price Down 1.2% - Here's Why

July 24, 2025 | marketbeat.com

SBC: Recent Growth Initiatives, Takeaways Regarding 2Q25 / 2025

July 23, 2025 | finance.yahoo.com

SBC Medical Group (NASDAQ:SBC) Sees Large Volume Increase - Here's What Happened

July 21, 2025 | marketbeat.com

SBC Medical Group (NASDAQ:SBC) Trading Down 4% - Should You Sell?

July 19, 2025 | marketbeat.com

SBC Medical Group (NASDAQ:SBC) Shares Gap Down - Should You Sell?

July 18, 2025 | marketbeat.com

SBC Medical Group Acquires MB Career Lounge: "JUN CLINIC" Joins the Group, Strengthening Competitive Position in a Growing Market

July 17, 2025 | finance.yahoo.com

SBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global Expansion

July 15, 2025 | joplinglobe.comJ

SBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global Expansion

July 14, 2025 | businesswire.com

SBC Stock Price Quote - Morningstar

July 13, 2025 | morningstar.comM

Returns on Capital Paint A Bright Future For SBC Medical Group Holdings (NASDAQ:SBC)

July 8, 2025 | finance.yahoo.com

SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power - Seeking Alpha

July 3, 2025 | seekingalpha.com

SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power

July 1, 2025 | globenewswire.com

SBC Medical added to membership of Russell 3000® Index

June 27, 2025 | financialpost.comF

SBC Medical Group Holdings Inc News (SBC) - Investing.com

June 26, 2025 | investing.com

SBC Medical Participated in 4 Investor Conferences in May and June 2025

June 23, 2025 | globenewswire.com

Participation in “The 113th Congress of Japan Society of Aesthetic Surgery,” May 2025

June 18, 2025 | bakersfield.comB

Participation in "The 113th Congress of Japan Society of Aesthetic Surgery,” May 2025

June 17, 2025 | manilatimes.netM

Participation in â€œThe 113th Congress of Japan Society of Aesthetic Surgery,â€ May 2025

June 17, 2025 | globenewswire.com

SBC Medical Group Holdings Incorporated Announces Participation in Upcoming Investor Events

May 28, 2025 | quiverquant.comQ

SBC Medical Announces Attendance at Upcoming Investor Events

May 28, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SBC, PACS, CELC, and LFST Company Descriptions

Celcuity NASDAQ:CELC

$50.06 +3.40 (+7.29%)

Closing price 04:00 PM Eastern

Extended Trading

$50.10 +0.04 (+0.08%)

As of 05:38 PM Eastern

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

LifeStance Health Group NASDAQ:LFST

$4.66 +0.09 (+1.97%)

Closing price 04:00 PM Eastern

Extended Trading

$4.93 +0.27 (+5.71%)

As of 05:39 PM Eastern

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

PACS Group NYSE:PACS

$11.22 -0.14 (-1.24%)

Closing price 03:59 PM Eastern

Extended Trading

$11.45 +0.23 (+2.06%)

As of 05:39 PM Eastern

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

SBC Medical Group NASDAQ:SBC

$4.54 +0.10 (+2.25%)

Closing price 04:00 PM Eastern

Extended Trading

$4.53 -0.01 (-0.22%)

As of 05:31 PM Eastern

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time